WallStreetZenWallStreetZen

NASDAQ: CVKD
Cadrenal Therapeutics Inc Stock Ownership - Who owns Cadrenal Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cadrenal Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Quang X. PhamChairman and CEO2026-06-297,400$3.03
$22.42kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-269,029$3.05
$27.54kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-252,127$3.00
$6.38kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-232,277$3.20
$7.29kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-229,167$3.55
$32.54kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-17513$3.16
$1.62kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-163,613$3.18
$11.49kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-153,666$3.58
$13.12kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-1212,996$3.94
$51.20kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-111,462$4.12
$6.02kSell

1 of 5

CVKD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CVKD insiders and whales buy or sell their stock.

CVKD Shareholders

What type of owners hold Cadrenal Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
John Raymond Murphy21.43%614,792$1.28MInsider
Quang X. Pham10.41%298,589$624.05kInsider
Glynn Wilson1.74%50,000$104.50kInsider
Vanguard Capital Management LLC1.58%45,201$94.47kInstitution
Steven Zelenkofske1.39%40,000$83.60kInsider
Geode Capital Management LLC0.75%21,626$45.20kInstitution
Vanguard Fiduciary Trust Co0.29%8,311$17.37kInstitution
Jpmorgan Chase Co0.26%7,500$15.68kInstitution
Blackrock Inc0.19%5,496$11.49kInstitution
Lee Scott Golden0.06%1,667$3.48kInsider

1 of 3

CVKD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CVKD3.18%35.04%Net SellingNet Selling
ENVB1.49%18.91%
XBIO3.90%96.10%
CURX1.16%8.68%
PCSA5.02%94.98%Net BuyingNet Buying
View Top Biotech Stocks

Cadrenal Therapeutics Stock Ownership FAQ

Who owns Cadrenal Therapeutics?

Cadrenal Therapeutics (NASDAQ: CVKD) is owned by 3.18% institutional shareholders, 35.04% Cadrenal Therapeutics insiders, and 61.78% retail investors. John Raymond Murphy is the largest individual Cadrenal Therapeutics shareholder, owning 614,792.00 shares representing 21.43% of the company. John Raymond Murphy's Cadrenal Therapeutics shares are currently valued at $1.24M.

If you're new to stock investing, here's how to buy Cadrenal Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.